Five Prime Therapeutics Inc Logo Image

Five Prime Therapeutics Inc

Five Prime Therapeutics Inc has reached its limit for report views.

Please check back to see if Five Prime Therapeutics Inc has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

Most Recent Annual Report

2016 Annual Report and Form 10K

Five Prime Therapeutics Inc
Order Free Hardcopy

You can request a free hardcopy of this report mailed to you by clicking the button below.

Add Annual Report

Archived Annual Reports

  • Five Prime Therapeutics Inc
  • Five Prime Therapeutics Inc
  • Five Prime Therapeutics Inc

About Five Prime Therapeutics Inc

51-200 Employees
Based in San Francisco, California

Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes. The company’s product candidates include FPA008, an antibody that inhibits colony stimulating factor-1 receptor and is in Phase Ib clinical trials for the treatment of rheumatoid arthritis; and in pre-IND stage for pigmented villonodular synovitis and multiple cancers in combination with nivolumab.

Ticker:
FPRX
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol